Ian Quirt

18.8k total citations
80 papers, 2.8k citations indexed

About

Ian Quirt is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ian Quirt has authored 80 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Oncology, 23 papers in Molecular Biology and 20 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ian Quirt's work include Melanoma and MAPK Pathways (17 papers), Cutaneous Melanoma Detection and Management (15 papers) and Sarcoma Diagnosis and Treatment (13 papers). Ian Quirt is often cited by papers focused on Melanoma and MAPK Pathways (17 papers), Cutaneous Melanoma Detection and Management (15 papers) and Sarcoma Diagnosis and Treatment (13 papers). Ian Quirt collaborates with scholars based in Canada, United States and New Zealand. Ian Quirt's co-authors include B. Cummings, Victor Fornasier, Manya Charette, Kate Bak, Brian O’Sullivan, Shailendra Verma, Teresa M. Petrella, Robert S. Bell, Charles Catton and Susan Burdette-Radoux and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Ian Quirt

80 papers receiving 2.7k citations

Peers

Ian Quirt
Mustafa Beneklı Türkiye
Carl Plager United States
Marco Danova Italy
Fariba Navid United States
Steven J. Lemery United States
Dusan Kotasek Australia
George D. Demetri United States
Megan L. Troxell United States
Ronald G. Stoller United States
Peter Langmuir United States
Mustafa Beneklı Türkiye
Ian Quirt
Citations per year, relative to Ian Quirt Ian Quirt (= 1×) peers Mustafa Beneklı

Countries citing papers authored by Ian Quirt

Since Specialization
Citations

This map shows the geographic impact of Ian Quirt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian Quirt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian Quirt more than expected).

Fields of papers citing papers by Ian Quirt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ian Quirt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian Quirt. The network helps show where Ian Quirt may publish in the future.

Co-authorship network of co-authors of Ian Quirt

This figure shows the co-authorship network connecting the top 25 collaborators of Ian Quirt. A scholar is included among the top collaborators of Ian Quirt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ian Quirt. Ian Quirt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McWhirter, Elaine, Ian Quirt, Thomas F. Gajewski, et al.. (2016). A phase II study of cediranib, an oral VEGF inhibitor, in previously untreated patients with metastatic or recurrent malignant melanoma. Investigational New Drugs. 34(2). 231–235. 7 indexed citations
2.
Haas, Naomi B., Ian Quirt, Sébastien J. Hotte, et al.. (2014). Phase II trial of vorinostat in advanced melanoma. Investigational New Drugs. 32(3). 526–534. 47 indexed citations
3.
Wainstein, Alberto Julius Alves, Salvador Martín‐Algarra, Lars Bastholt, et al.. (2014). Melanoma Early Detection and Awareness. American Journal of Therapeutics. 22(1). 37–43. 11 indexed citations
4.
Petrella, Teresa M., S. Verma, Karen Spithoff, Ian Quirt, & David R. McCready. (2012). Adjuvant Interferon Therapy for Patients at High Risk for Recurrent Melanoma: An Updated Systematic Review and Practice Guideline. Clinical Oncology. 24(6). 413–423. 41 indexed citations
5.
Hersey, Peter, Lars Bastholt, Vanna Chiarion‐Sileni, et al.. (2009). Small molecules and targeted therapies in distant metastatic disease. Annals of Oncology. 20. vi35–vi40. 72 indexed citations
6.
Karkouti, Keyvan, et al.. (2006). Intravenous iron and recombinant erythropoietin for the treatment of postoperative anemia. Canadian Journal of Anesthesia/Journal canadien d anesthésie. 53(S1). 11–19. 68 indexed citations
7.
Margolin, Kim, Jeff Longmate, Timothy W. Synold, et al.. (2005). CCI‐779 in metastatic melanoma. Cancer. 104(5). 1045–1048. 188 indexed citations
8.
Turner, Robert C., Ronald L. Burkes, Félix Couture, et al.. (2001). Epoetin Alfa in Cancer Patients. Journal of Pain and Symptom Management. 22(5). 954–965. 34 indexed citations
9.
Stewart, A. Keith, Norman J. Lassam, Ian Quirt, et al.. (1999). Adenovector-mediated gene delivery of interleukin-2 in metastatic breast cancer and melanoma: results of a phase 1 clinical trial. Gene Therapy. 6(3). 350–363. 108 indexed citations
10.
11.
Dranitsaris, George, et al.. (1997). Cost-Benefit Analysis of Prophylactic Granulocyte Colony-Stimulating Factor During CHOP Antineoplastic Therapy for Non-Hodgkinʼs Lymphoma. PharmacoEconomics. 11(6). 566–577. 12 indexed citations
12.
13.
Knowling, Margaret A., et al.. (1994). Phase II trial of 10-EDAM in advanced soft tissue sarcoma. Annals of Oncology. 5(8). 766–768. 7 indexed citations
14.
Verma, Sunil, Ian Quirt, E. Eisenhauer, et al.. (1993). A phase II study of weekly Edatrexate (10-EDAM) in metastatic melanoma. Annals of Oncology. 4(3). 254–255. 7 indexed citations
15.
Meyer, Ralph M., Ian Quirt, Jamey Skillings, et al.. (1993). Escalated as Compared with Standard Doses of Doxorubicin in BACOP Therapy for Patients with Non-Hodgkin's Lymphoma. New England Journal of Medicine. 329(24). 1770–1776. 45 indexed citations
16.
O’Sullivan, Brian, Charles Catton, Robert S. Bell, et al.. (1993). Outcome and prognostic factors in soft tissue sarcoma in the adult. International Journal of Radiation Oncology*Biology*Physics. 27(5). 1091–1099. 156 indexed citations
17.
18.
Amato, Dominick & Ian Quirt. (1990). Lecture handouts of projected slides in a medical course. Medical Teacher. 12(3-4). 291–296. 5 indexed citations
19.
Kerr, I B, et al.. (1986). Toxicity of oral N-methylformamide in three phase II trials: a report from the National Cancer Institute of Canada Clinical Trials Group.. PubMed. 70(7). 881–3. 10 indexed citations
20.
Quirt, Ian, et al.. (1972). Leukemia on myeloma.. BMJ. 1(5794). 248.1–248. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mustafa Beneklı Breakdown of academic impact, for papers by Carl Plager Breakdown of academic impact, for papers by Marco Danova Breakdown of academic impact, for papers by Fariba Navid Breakdown of academic impact, for papers by Steven J. Lemery Breakdown of academic impact, for papers by Dusan Kotasek Breakdown of academic impact, for papers by George D. Demetri Breakdown of academic impact, for papers by Megan L. Troxell Breakdown of academic impact, for papers by Ronald G. Stoller Breakdown of academic impact, for papers by Peter Langmuir
Rankless by CCL
2026